Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
12548 | 835 | 51.4 | 93% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | VPR | Author keyword | 153 | 67% | 17% | 138 |
2 | VPX | Author keyword | 74 | 81% | 5% | 44 |
3 | HIV 1 VPR | Author keyword | 65 | 95% | 3% | 21 |
4 | SAMHD1 | Author keyword | 53 | 70% | 5% | 44 |
5 | DCAF1 | Author keyword | 13 | 80% | 1% | 8 |
6 | RETROVIROL HUMAINE | Address | 9 | 59% | 1% | 10 |
7 | CELL CYCLE G2 ARREST | Author keyword | 8 | 100% | 1% | 5 |
8 | CAPSID TARGETED VIRAL INACTIVATION CTVI | Author keyword | 4 | 75% | 0% | 3 |
9 | GRP NEUROMUSCULAR MITOCHONDRIAL DISORDERS | Address | 4 | 75% | 0% | 3 |
10 | HIV 1VPR | Author keyword | 4 | 75% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | VPR | 153 | 67% | 17% | 138 | Search VPR | Search VPR |
2 | VPX | 74 | 81% | 5% | 44 | Search VPX | Search VPX |
3 | HIV 1 VPR | 65 | 95% | 3% | 21 | Search HIV+1+VPR | Search HIV+1+VPR |
4 | SAMHD1 | 53 | 70% | 5% | 44 | Search SAMHD1 | Search SAMHD1 |
5 | DCAF1 | 13 | 80% | 1% | 8 | Search DCAF1 | Search DCAF1 |
6 | CELL CYCLE G2 ARREST | 8 | 100% | 1% | 5 | Search CELL+CYCLE+G2+ARREST | Search CELL+CYCLE+G2+ARREST |
7 | CAPSID TARGETED VIRAL INACTIVATION CTVI | 4 | 75% | 0% | 3 | Search CAPSID+TARGETED+VIRAL+INACTIVATION+CTVI | Search CAPSID+TARGETED+VIRAL+INACTIVATION+CTVI |
8 | HIV 1VPR | 4 | 75% | 0% | 3 | Search HIV+1VPR | Search HIV+1VPR |
9 | UNG2 | 3 | 50% | 1% | 5 | Search UNG2 | Search UNG2 |
10 | TRIPHOSPHOHYDROLASE | 3 | 100% | 0% | 3 | Search TRIPHOSPHOHYDROLASE | Search TRIPHOSPHOHYDROLASE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | VIRAL PROTEIN R | 143 | 74% | 13% | 105 |
2 | TYPE 1 VPR | 122 | 84% | 8% | 67 |
3 | RESTRICTION FACTOR SAMHD1 | 79 | 64% | 9% | 76 |
4 | HIV 1 VPR | 76 | 62% | 9% | 78 |
5 | DEOXYNUCLEOSIDE TRIPHOSPHATE TRIPHOSPHOHYDROLASE | 49 | 94% | 2% | 17 |
6 | VIRION ASSOCIATED PROTEIN | 48 | 70% | 5% | 40 |
7 | VIRION INCORPORATION | 45 | 46% | 9% | 72 |
8 | PROTEIN VPR | 41 | 87% | 2% | 20 |
9 | REGULATORY PROTEIN VPR | 38 | 84% | 3% | 21 |
10 | VPX | 37 | 61% | 5% | 40 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates | 2012 | 190 | 46 | 50% |
The Vpr protein from HIV-1: distinct roles along the viral life cycle | 2005 | 97 | 176 | 74% |
Structure-Function Relationship of Vpr: Biological Implications | 2009 | 23 | 234 | 73% |
Limelight on two HIV/SIV accessory proteins in macrophage infection: Is Vpx overshadowing Vpr? | 2010 | 35 | 133 | 62% |
Human immunodeficiency virus type 1 Vpr: functions and molecular interactions | 2009 | 23 | 104 | 72% |
Vpr and Its Interactions with Cellular Proteins | 2009 | 20 | 152 | 72% |
HIV-1 Vpr: Mechanisms of G(2) arrest and apoptosis | 2008 | 48 | 141 | 60% |
HIV-1 Vpr-a still "enigmatic multitasker" | 2014 | 5 | 183 | 62% |
New insights into an X-traordinary viral protein | 2014 | 4 | 136 | 65% |
HIV-1 Vpr: A Closer Look at the Multifunctional Protein from the Structural Perspective | 2009 | 9 | 101 | 82% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | RETROVIROL HUMAINE | 9 | 59% | 1.2% | 10 |
2 | GRP NEUROMUSCULAR MITOCHONDRIAL DISORDERS | 4 | 75% | 0.4% | 3 |
3 | PITTSBURGH HIV PROT INTERACT | 2 | 24% | 1.0% | 8 |
4 | EMERGING INFECT DISSTATE VIROL | 2 | 67% | 0.2% | 2 |
5 | ORETRO UNITE VIROL HUMAINE 758 | 2 | 67% | 0.2% | 2 |
6 | UMR 860 | 2 | 67% | 0.2% | 2 |
7 | CELLULAR BIOL IMMUNOL | 2 | 24% | 1.0% | 8 |
8 | VIRAL INFECT DIS UNIT | 2 | 20% | 1.1% | 9 |
9 | VIROL AIDS | 2 | 19% | 1.0% | 8 |
10 | RETROVIRUS UNIT | 2 | 23% | 0.7% | 6 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000188984 | APOBEC3G//VIF//APOBEC3F |
2 | 0.0000175480 | VPU//BST 2//TETHERIN |
3 | 0.0000139249 | EMI U 9922//UNITE PHYSIOPATHOL INFECT LENTIVIRALES//DIPARTIMENTO IGIENE MED PREVENT SANITA PUBBL |
4 | 0.0000121830 | AICARDI GOUTIERES SYNDROME//TREX1//RIBONUCLEASE H |
5 | 0.0000116961 | NEF//HIV 1 NEF//HIV NEF |
6 | 0.0000092631 | TRIM5 ALPHA//TRIMCYP//TRIM5 |
7 | 0.0000085045 | VIRUS CELL INTERACT SECT//GAG//M PMV |
8 | 0.0000070024 | HIV 1 INTEGRASE//INTEGRASE//RALTEGRAVIR |
9 | 0.0000055919 | HIV LATENCY//HIV CURE//HIV 1 LATENCY |
10 | 0.0000054036 | TAT//TAT PROTEIN//TAR RNA |